People: Dendreon Corp (DNDN.O)
10 Dec 2013
Mr. Joseph I. DePinto has been appointed as Executive Vice President - Commercial Operations of Dendreon Corp., effective February 28, 2012. Previously, Mr. DePinto served as Vice President Product Champion at ImClone, a wholly-owned subsidiary of Eli Lilly and Company, for IMC-11F8 (necitumumab) from July 2010 until February 2012. Prior to that time, Mr. DePinto served as Vice President of U.S. Sales and Marketing at Abraxis Bioscience, an oncology biotech company and now a wholly-owned subsidiary of Celgene Corporation, from October 2009 until March 2010. Mr. DePinto also served as Vice President, Commercial Operations for ImClone from July 2008 until October 2009, and Global Marketing Leader of Oncology Therapeutics at Johnson & Johnson Pharmaceutical Services, Inc. from January 2006 until July 2008. Mr. DePinto has spent 20 years of his career working in oncology at both pharmaceutical and biotech companies. He earned his Bachelor of Science in Marketing and his Master of Business Administration in Pharmaceutical Chemical Studies from Fairleigh Dickinson University.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|